Back to Results
First PageMeta Content



Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Colin Weekes,1
Add to Reading List

Document Date: 2016-10-09 05:13:10

Open Document

File Size: 321,05 KB

Share Result on Facebook
UPDATE